Anbio Biotechnology (NNNN) Equity Ratio (2023 - 2025)

Anbio Biotechnology's quarterly Equity Ratio came in at 1.0 in Q4 2025, up 9.74% year-on-year from 0.91 in Q4 2024, and up 9.74% quarter-over-quarter from 0.91 in Q4 2024.

Anbio Biotechnology has reported Equity Ratio for 3 years, with the latest figure at 1.0 in Q4 2025.

  • For the quarter ending Q4 2025, Equity Ratio rose 9.74% year-over-year to 1.0; the trailing twelve-month figure through Dec 2025 stood at 1.0 (up 9.74% YoY), and the FY2025 full-year result was 1.0, up 9.74% from the prior year.
  • Equity Ratio for Q4 2025 stood at 1.0, up from 0.91 in the prior quarter.
  • The five-year high for Equity Ratio was 1.0 in Q4 2025, with the low at 0.91 in Q4 2024.
  • Average Equity Ratio over 3 years is 0.95, with a median of 0.94 recorded in 2023.
  • Year-over-year, Equity Ratio declined 3.06% in 2024 and rose 9.74% in 2025.
  • Tracing NNNN's Equity Ratio over 3 years: stood at 0.94 in 2023, then decreased by 3.06% to 0.91 in 2024, then increased by 9.74% to 1.0 in 2025.
  • The last three Equity Ratio figures came in at 1.0 (Q4 2025), 0.91 (Q4 2024), and 0.94 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 0.88
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 0.47
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 0.74
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 0.73
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 0.35
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 0.67
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 0.66
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 0.30
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 0.52
10 Anbio Biotechnology 1.32 Bn 1.31 Bn - 1.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 1.00
Dec 31, 2024 0.91
Dec 31, 2023 0.94